Literatur
Behrens-Baumann W (1999) Mycosis and the eye and its adnexa. Karger, Basel
Behrens-Baumann W (2009) Diagnostik und Therapie der Keratomykose. Ophthalmologe 106:471–481
Behrens-Baumann W (2010) Herpes simplex Keratitis. Ein kurzer Überblick zur aktuellen Therapie. Klin Monatsbl Augenheilkd 227:338–392
Behrens-Baumann W, Küster M (1987) Der Einfluss von Kortikosteroiden bei der antimykotischen Therapie der Candida-Keratitis. Klin Monatsbl Augenheilkd 191:222–225
Behrens-Baumann W, Pleyer U (2007) Therapie und Prognose der bakteriellen Keratitis. Ophthalmologe 104:15–20
Behrens-Baumann W, Paul HH, Ansorg R (1981) Der Einfluss von Cortison bei der Behandlung der Pseudomonas-aeruginosa-Keratitis. Klin Monatsbl Augenheilkd 178:200–202
Behrens-Baumann W, Finis D, MacKenzie C et al (2015) Keratomykose – Therapiestandards und aktuelle Entwicklungen. Klin Monatsbl Augenheilkd 232:754–764
Benson H (1974) Permeability of the cornea to topically applied drugs. Arch Ophthalmol 91:313–327
Kain HL (1997) Prinzipien in der Behandlung der Endophthalmitis. Klin Monatsbl Augenheilkd 210:274–288
Leibowitz HM, Kupferman A (1980) Topically administered corticosteroids: effect on antibiotictreated bacterial keratitis. Arch Ophthalmol 98:1287–1290
Maurice D (1960) The permeability of the cornea. In: Duke-Elder S, Perkins ES (Hrsg) The transparency of the cornea. Blackwell, Oxford, S 67–71
Newmark E, Kaufman HE, Polack FM et al (1971) Clinical experience with pimaricin therapy in fungal keratitis. South Med 64:935–941
O’Day DM, Moore TE, Aronson SB (1971) Deep fungal corneal abscess. Combined corticosteroid therapy. Arch Ophthalmol 86:414–419
Pleyer U, Mondino PJ, Adamu SA et al (1992) Immune response to Staphylococcus epidermidis endophthalmitis in a rabbit model. Invest Ophthalmol Vis Sci 33:2650–2663
Ray KJ, Srinivasan M, Mascarenhas J et al (2014) Early addition of corticosteroids in the treatment of bacterial keratis. JAMA Ophthalmol 132:737–741
Robaei D, Carnt N, Watson S (2016) Established and emerging ancillary techniques in management of microbial keratitis: a review. Brit J Ophthalmol. doi:10.1136/bjophthalmol-2015-307371
Roberts SS (1957) Nystatin in monilia keratoconjunctivitis. Am J Ophthalmol 44:108–109
Schreiber W, Olbrisch A, Vorwerk CK et al (2003) Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis. Invest Ophthalmol Vis Sci 44:2634–2643
Seitz B, Heiligenhaus A (2015) Das Chamäleon der Keratitis herpetischer Genese – Diagnose und Therapie. Klin Monatsbl Augenheilkd 232:745–753
Siemieniuk RAC, Meade MO, Alonso-Coello P et al (2015) Corticosteroid therapy for patients hospitalized with community-aquired pneumonia. Ann Intern Med 163:519–528
Srinivasan M, Mascarenhas J, Rajaraman R (2012) Corticosteroids in bacterial keratitis -The steroids for corneal ulcers trial (SCUT). Arch Ophthalmol 130:143–150
Stern GA, Buttross M (1991) Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease. Ophthalmology 98:847–853
Sundmacher R (2009) Color Atlas of Herpetic Eye Disease. Springer, Berlin Heidelberg
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
W. Behrens-Baumann gibt an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Behrens-Baumann, W. Kortikosteroide als Additiv zur antimikrobiellen Therapie. Ophthalmologe 113, 964–965 (2016). https://doi.org/10.1007/s00347-016-0352-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-016-0352-3